Criteria for Participation in CVBT-141H

To qualify for our Phase II trial (CVBT-141H), you must be between 25 and 75 years of age with at least a 3 month history of chronic stable angina triggered by physical exertion, of Canadian Cardiovascular Society (CCS) anginal classification III or IV while receiving optimal medical therapy.

You must also have documentation of narrowing of a major coronary artery or diffuse type of CHD. Their treating cardiologist will have determined that they are generally not suitable for interventional therapy or CABG surgery.

It is intended that at least 120 evaluable subjects will be enrolled at 30 centers in the USA, Canada, Europe, and Russia.

< Back to Clinical Trials                            Go to The Procedure >

Skip to Locations & Inquiries >>

Use of this site constitutes agreement to our Terms and Conditions
and Privacy Policy. Site Design and Contents © 2008 CardioVascular BioTherapeutics, Inc. All Rights Reserved.

Some content on this site requires the free Adobe Reader.